The measurement of chemical substances, their metabolites, or markers of health effects in human specimens (such as blood or urine) to assess exposure levels and potential health risks, informing regulatory priorities and the effectiveness of restrictions.
Foresight tracks Human Biomonitoring developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.
Not ready for a trial? Take the 3-minute readiness assessment
Current activity
54% below the prior 8-week baseline
3-month trend
Latest alerts below
Last updated
22 May 2026, 18:58
Source-backed regulatory and guidance signals tracked by Foresight, with the newest developments first.
Delaware Enacts HB 312 Updating Childhood Lead Testing Definition
Delaware has enacted HB 312, effective 21 May 2026, updating its Childhood Lead Poisoning Prevention Act to broaden the statutory definition of confirmatory lead testing for children. The change allows confirmed cases to be based on two capillary blood screenings as well as venous draws, so healthcare providers and public health programs must update testing protocols and prepare for related regulatory changes that improve early detection of lead exposure.
United StatesEFSA Procurement Tender on Human Biomonitoring in Chemical Risk Assessment
EFSA has launched a €600,000 procurement tender to develop a comprehensive strategy for integrating human biomonitoring data into its chemical risk assessment processes, with bids due by 3 June 2026. This work will shape how future EU decisions use real-world human exposure evidence, potentially shifting risk assessment expectations for chemicals and products across affected sectors.
European UnionNew Hampshire Proposes Amendments to Lead Poisoning Prevention and Control Rules (He-P 1600)
New Hampshire has proposed readopting with amendments its He-P 1600 Lead Poisoning Prevention and Control rules, updating definitions, procedures, online processes and fines for lead hazard reduction and professional licensing, with a hearing on 17 June 2026 and comments due 24 June 2026. These changes will tighten and clarify obligations for property owners, lead contractors, laboratories and training providers, so affected organisations should review their lead compliance, tenant communication and reporting processes in anticipation of a revised state programme.
United StatesPARC Advances Integrative Risk Assessment and Provides Rapid Response Data to EFSA
In May 2026, the EU Partnership for the Assessment of Risks from Chemicals (PARC) announced new integrative mixture risk-assessment deliverables, expanded training for regulators, and Rapid Response data used by EFSA in its assessment of Alternaria toxins in food and feed. These scientific outputs do not create new legal obligations but signal a stronger evidence base and tools that could shape future EU chemical and food-safety policies, especially around mixture exposures, human biomonitoring and natural toxins.
European UnionMichigan MDHHS Releases PFAS Biomonitoring Findings for Firefighters
In May 2026 the Michigan Department of Health and Human Services published statewide PFAS biomonitoring results for more than 1,000 firefighters, establishing reference blood concentrations for 13 PFAS and confirming that PFOS and PFHxS are detectable in over 95% of participants. These findings suggest that Michigan’s 2020 PFAS foam controls are reducing average exposures but leave pockets of higher risk, particularly for airport and urban firefighters, underscoring the need to sustain foam substitution, stringent PPE and decontamination practices, and continued policy development on firefighter PFAS exposure.
United StatesUS Study Finds Multiple PFAS 'Forever Chemicals' in 98.5% of People Tested
A major US biomonitoring study of 10,566 blood samples finds that 98.8% of samples contained at least one PFAS and 98.5% contained multiple "forever chemicals", with recurring combinations of five or more PFAS across the population. Although it does not create new legal duties, the research strengthens the evidence base for mixture-based PFAS risk assessment and could support future regulatory limits, clinical guidance and litigation over combined PFAS burdens.
United StatesNorwegian Institute of Public Health Study Suggests PFAS Exposure in Norway Is Underestimated
Norway’s public health institute has published new biomonitoring data indicating that the short-chain PFAS compound trifluoroacetic acid (TFA) is now the dominant PFAS detected in Norwegian blood samples and that known PFAS, even including TFA, explain only about half of total organofluorine exposure. This evidence highlights significant blind spots in current PFAS monitoring and suggests that future European restrictions and national risk assessments may need to account for TFA, unidentified organofluorine and fluorinated pharmaceuticals when judging real-world exposure and health risk.
NorwayUK Environmental Audit Committee Chair Calls For PFAS Health Monitoring In Bentham
In April 2026, the chair of the UK Parliament’s Environmental Audit Committee publicly urged health monitoring for residents in Bentham and other areas with high PFAS contamination following an ENDS/ITV investigation. This political pressure signals growing scrutiny of PFAS hotspots and could drive new government-led biomonitoring programmes or wider UK policy responses on PFAS exposure and remediation.
United KingdomEU Parliament ITRE Committee Publishes Amendments 399–759 To Horizon Europe 2028–2034 Draft Regulation
In April 2026 the European Parliament’s ITRE committee tabled amendments 399–759 to its draft regulation establishing the Horizon Europe 2028–2034 research framework, adding language on climate, biodiversity, circularity, research security and environmental health. If carried into the final programme, these priorities would channel substantial EU research and innovation funding toward areas such as exposome and safer-chemicals research, pollution and plastics monitoring, and strategic technologies, shaping future project opportunities and the evidence base for later regulatory decisions.
European UnionEuropean Parliament ITRE Amendments to Draft Horizon Europe 2028–2034 Regulation – Including Proposed Human Exposome Mission
The European Parliament’s ITRE committee has tabled extensive amendments to the draft Horizon Europe 2028–2034 regulation, including a proposed new mission on the human exposome that would fund large-scale research on environmental and lifestyle exposures. If retained in the final framework, this mission would channel EU R&I resources into exposure and biomonitoring data that can shape future chemicals regulation, occupational health standards, and broader risk-based policy across the Union.
European UnionMinnesota Senate Introduces SF 5170 to Fund Dakota County Lead Exposure Study
Minnesota legislators have introduced SF 5170 to provide a fiscal 2027 general-fund grant for Dakota County Public Health to study lead exposure risks among county residents. By targeting emission sources, recent standard exceedances, and impacts on young children and pregnant women, the study signals heightened scrutiny that could drive future remediation, enforcement, or reporting obligations for nearby facilities and public agencies.
United StatesUNEP Opens Registration for 2026 Global Interlaboratory Assessment on POPs and Mercury
UNEP has opened registration for the 2026 Fifth Global Interlaboratory Assessment on POPs and mercury under its Global Chemicals Monitoring Programme, with laboratories worldwide invited to register by 15 May 2026. The exercise will generate harmonised monitoring data to support effectiveness evaluations of the Stockholm and Minamata Conventions and help laboratories benchmark and improve their analytical performance for POPs and mercury.
GlobalGermany (BAuA) Highlights New Measurement Methods for Workplace Air Monitoring and Biomonitoring
BAuA has highlighted a new 2026 DFG Senate Commission article in Gefahrstoffe presenting updated analytical methods for workplace air monitoring and biomonitoring. These methods will strengthen the scientific basis for occupational exposure assessment and biomonitoring campaigns, informing how regulators, employers, and laboratories design measurements and interpret results over time.
GermanyMaine Enacts Law Establishing Base Gagetown Chemical-Exposure Registry And Study Commission
Maine has enacted a law (Public Law Chapter 763, LD 1640) creating a Base Gagetown Training Registry for exposed service members and reestablishing the Gagetown Harmful Chemical Study Commission, effective with the Governor’s approval on 16 April 2026. This formalises long-term monitoring and research on harmful chemical exposure among affected veterans, signalling sustained policy attention that could inform future benefits decisions, remediation priorities, and related chemical-exposure regulation.
United StatesNew York Senate Introduces Bill S9496 Requiring PFAS Blood Testing Coverage Under Medicaid and Private Insurance
In March 2026, New York introduced Senate Bill S9496 to require Medicaid and state-regulated health insurers to cover PFAS blood testing and to define PFAS in insurance and social services law. If enacted, this would expand access to PFAS exposure testing, strengthen public health monitoring in affected communities, and signal increased state-level scrutiny of PFAS contamination and related healthcare costs.
United StatesITV and ENDS Investigation Finds Elevated PFAS Blood Levels in Bentham, North Yorkshire Residents
An ITV and ENDS investigation in March 2026 found significantly elevated PFAS blood levels among residents and workers in Bentham, North Yorkshire, near a former PFAS firefighting foam factory. While no new UK legal thresholds or enforcement actions have been triggered, the findings intensify scrutiny of legacy PFAS contamination and could drive stricter risk assessment, remediation expectations, and future regulatory limits around industrial PFAS use.
United KingdomSwedish Study Finds Very High Prenatal PFAS Exposure Increases Childhood Asthma Risk
A new PLOS Medicine cohort study of 11,488 children in southern Sweden finds that very high prenatal PFAS exposure from decades of AFFF-contaminated drinking water in Ronneby is associated with a markedly higher incidence of childhood asthma. These results highlight a substantial, previously under-recognised public health burden from extreme PFAS contamination, likely increasing pressure for stricter drinking-water standards, remediation, and liability exposure in highly contaminated communities.
SwedenRIVM and Partners Develop Human PBK Model for PFOA to Support PFAS Risk Assessment
Dutch and European researchers have launched a high-precision human kinetic model for PFOA that enables risk assessments without animal testing. This methodology is expected to accelerate the adoption of more stringent health-based guidance values and streamline regulatory restrictions across the wider PFAS substance group.
NetherlandsGlobal Public Health Experts Issue Seattle Statement Urging Stricter Glyphosate Regulation
Global health experts have issued the Seattle Statement calling for the phase-out or stricter regulation of glyphosate due to systemic health risks. This consensus intensifies pressure on regulators to overhaul pesticide risk assessments and signals significant long-term litigation and market access risks for glyphosate-based products.
GlobalUnited StatesNetherlands Ministry of Health Answers Chemelot Health Questions and Plans Decision on National Biomonitoring Programme
The Dutch government will decide on a national chemical biomonitoring programme by mid-2026 to monitor population exposure near major industrial clusters. This move toward structural health tracking and cost-attribution frameworks signals heightened liability risks and potential for stricter emission limits for chemical manufacturers.
NetherlandsThese are just a few of the most recent Human Biomonitoring alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.
Start free trialTopic context
Definition
The measurement of chemical substances, their metabolites, or markers of health effects in human specimens (such as blood or urine) to assess exposure levels and potential health risks, informing regulatory priorities and the effectiveness of restrictions.
Industry relevance
Human Biomonitoring developments can change product scope, supplier expectations, market access, reporting duties, and risk ownership. Foresight tracks the signals early so teams can respond before obligations become urgent.
Foresight tracking
Foresight monitors official sources, extracts structured regulatory intelligence, and maps alerts to a customer's products, substances, markets, and priorities so teams see the relevant signal with source evidence for review.
Everything you need to know about Foresight's regulatory intelligence platform
Still have questions? Get in touch with our team
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at
